Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
RESEARCH TOOLSreports
Holding ELVN?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -23.16M | $ -19.72M | $ -25.99M | $ -24.25M | $ -16.72M |
| EBITDA | $ -23.08M | $ -18.98M | $ -25.91M | $ -24.17M | $ -16.65M |
| Net Income Common Stockholders | $ -23.16M | $ -19.95M | $ -22.74M | $ -20.77M | $ -16.72M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 291.83M | $ 312.39M | $ 320.50M | $ 263.48M | $ 277.87M |
| Total Assets | $ 305.43M | $ 327.04M | $ 342.78M | $ 274.04M | $ 288.50M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -291.83M | $ -312.39M | $ -320.50M | $ -263.48M | $ -277.87M |
| Total Liabilities | $ 17.03M | $ 22.11M | $ 25.07M | $ 12.29M | $ 9.51M |
| Stockholders Equity | $ 288.40M | $ 304.93M | $ 317.71M | $ 261.75M | $ 278.99M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -12.21M | $ -20.44M | $ -23.38M | $ -15.91M | $ -12.14M |
| Operating Cash Flow | $ -12.19M | $ -20.43M | $ -23.36M | $ -15.89M | $ -12.05M |
| Investing Cash Flow | $ 14.83M | $ -33.66M | $ -17.89M | $ -35.55M | $ -151.52M |
| Financing Cash Flow | $ 1.12M | $ 1.81M | $ 90.27M | $ -425.00K | $ -2.82M |